The second day of the conference “Towards Personalized Cancer Medicine” held this week at the CosmoCaixa museum in Barcelona, focused on cancer genomics and the identification of biomarkers for use in the prognosis and treatment of the disease. The conference program included 17 plenary presentations. Only have way over, the conference has already met the expectations of the attendees who have expressed their more than favorably reviews about the quality of the lectures and the organization of the program.

Around 300 cancer researchers from around the world are meeting this week in Barcelona at the international conference “Towards Personalized Cancer Medicine,” held at CosmoCaixa from May 18 to 21. Various experts, many of whom are considered to be leaders in the field, will present their work and recent findings with the common objective of discussing everything related to the individualized treatment of cancer. The congress, which is divided into six thematic units, was launched yesterday with the presentation of a series of papers on biology and cancer susceptibility.

In recent years, biotechnology has experienced an unprecedented revolution. The techniques that have been developed up until now, particularly in genetics, are opening up a wide range of new lines of research and promising applications. At the same time, these advances are uncovering new challenges for the field. Researcher Pere Puigdomènech spoke to local high school students in La Seu d'Urgell, in Spain’s Catalonia region, about the future of biotechnology, its opportunities, satisfactions, difficulties and new potential goals that involve not only researchers but also society at large.